These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16688431)

  • 1. Pharmaceutical policy in Italy: Theory, politics and practice.
    Garattini L; Cornago D
    Eur J Health Econ; 2006 Jun; 7(2):89-90. PubMed ID: 16688431
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmaceutical policy in Italy: towards a structural change?
    Ghislandi S; Krulichova I; Garattini L
    Health Policy; 2005 Apr; 72(1):53-63. PubMed ID: 15760698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [European drug policy: welcomed modernization but shortage of political proposals concerning industry and research].
    Alván G
    Lakartidningen; 2003 Oct; 100(44):3541-2. PubMed ID: 14651017
    [No Abstract]   [Full Text] [Related]  

  • 4. Healthcare reform debate intensifies over cost controls.
    Schwartz RM
    J Cardiovasc Manag; 1993; 4(3):44-6. PubMed ID: 10127232
    [No Abstract]   [Full Text] [Related]  

  • 5. The 1992 biotechnology agenda: a message for candidates Bush and Clinton.
    Duzan SA
    Healthspan; 1992 Sep; 9(8):12-5. PubMed ID: 10122052
    [No Abstract]   [Full Text] [Related]  

  • 6. [Development costs, regulation and audit in the German SHI Drug Sector].
    Kamp F; Walter P; Bücheler R
    Gesundheitswesen; 2014 Jan; 76(1):7-18. PubMed ID: 24446140
    [No Abstract]   [Full Text] [Related]  

  • 7. A dose of pharmaco-economics. Can health networks learn from the drug policies of managed care plans?
    Taylor KS; Hagland MM
    Hosp Health Netw; 1993 Jul; 67(13):33-6. PubMed ID: 8513368
    [No Abstract]   [Full Text] [Related]  

  • 8. Balancing health and industrial policy objectives in the pharmaceutical sector: lessons from Australia.
    Morgan S; McMahon M; Greyson D
    Health Policy; 2008 Aug; 87(2):133-45. PubMed ID: 18295927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remember the MaineRx.
    Kemp R
    Appl Health Econ Health Policy; 2014 Feb; 12(1):1-5. PubMed ID: 24420789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Better pharmaceutical price comparison studies are needed for meaningful evaluation of price-control policies.
    Value Health; 2008; 11(1):129-30. PubMed ID: 18179656
    [No Abstract]   [Full Text] [Related]  

  • 11. The rising cost of healthcare. Cost increases drive healthcare to the top of the domestic policy agenda.
    Ferman JH
    Healthc Exec; 2003; 18(2):70-1. PubMed ID: 12655890
    [No Abstract]   [Full Text] [Related]  

  • 12. [The electoral programs of political parties and Health: a handbook to guide].
    Quintaliani G; Rollino C; Sepe V; Di Iorio B
    G Ital Nefrol; 2013; 30(1):. PubMed ID: 25083524
    [No Abstract]   [Full Text] [Related]  

  • 13. OTA takes closer look at cost of drugs.
    Blankenau R
    Hospitals; 1993 Apr; 67(7):48-9. PubMed ID: 8458628
    [No Abstract]   [Full Text] [Related]  

  • 14. The other drug lords.
    Novak V
    Int J Health Serv; 1993; 23(2):263-73. PubMed ID: 8500946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs, technology use get extra attention in reform plan.
    Scott L
    Mod Healthc; 1993 Sep; 23(39):32. PubMed ID: 10128474
    [No Abstract]   [Full Text] [Related]  

  • 16. Painful remedies.
    Beck M; Hager M
    Newsweek; 1992 Oct; 120(16):31. PubMed ID: 10121907
    [No Abstract]   [Full Text] [Related]  

  • 17. Handling dissent.
    Meiches R
    Minn Med; 2004 Oct; 87(10):38-9. PubMed ID: 15559099
    [No Abstract]   [Full Text] [Related]  

  • 18. Oncology pharmaceutical funding in New Zealand: a different approach and a proposal.
    Beatty PA; Laking GR
    J Oncol Pract; 2015 May; 11(3):249-51. PubMed ID: 25829524
    [No Abstract]   [Full Text] [Related]  

  • 19. Stating their case. Debate shows details of candidates' health agendas.
    Tieman J
    Mod Healthc; 2004 May; 34(22):16. PubMed ID: 15202173
    [No Abstract]   [Full Text] [Related]  

  • 20. Can advocates keep congress focused on HIV?
    AIDS Alert; 2001 Dec; 16(12):157-8. PubMed ID: 11768874
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.